KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD

By sjmartinez • December 25, 2023

Mottl AK, Nicholas SB. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD. Am J Kidney Dis. 2023 Dec 21:S0272-6386(23)00883-1. doi: 10.1053/j.ajkd.2023.09.003. Epub ahead of print. PMID: 38142396.

Tags: Chronic kidney disease, commentary, diabetes, evidence-based recommendation, GLP-1 RAs, guideline, guideline implementation, Nephrology, nephrology best practices, ns-MRAs, Publications, SGLT2 inhibitors

A literature review and reflection on clinical trials: current challenges, future directions, and potential strategies to overcome practical barriers

Zhang K, Lampridis S, Simone CB 2nd, Negoi I, Peng Y, Shang B, Lin Y, Cheng Y, Yang F, Shelat VG, Kalantar-Zadeh K. A literature[...]

Seizure-Induced Rhabdomyolysis Complicated by Acute Kidney Injury: A Case Report

Kaur H, Kennedy HH, Nobakht N. Seizure-Induced Rhabdomyolysis Complicated by Acute Kidney Injury: A Case Report. Am J Case Rep. 2026 Aug 18;27:e951097. doi: 10.12659/AJCR.951097.[...]

The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials

Rastogi A, Sarkar M, Kawai K, Munoz G, Simon L, Hwang M, Khalid M, Rhee C. The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA[...]